A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII

被引：0

作者：

Maran, A ^{[1
]}

Crazzolara, D ^{[1
]}

Nicoletti, M ^{[1
]}

Costa, S ^{[1
]}

dal Pos, M ^{[1
]}

Tiengo, A ^{[1
]}

Avogaro, A ^{[1
]}

Bruttomesso, D ^{[1
]}

机构：

[1] Cattedra Malattie Metab, Padua, Italy

来源：

DIABETOLOGIA | 2005年 / 48卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

902

引用

页码：A328 / A328

页数：1

共 50 条

[1] Continuous subcutaneous insulin infusion (CSII)of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII
Hirsch, IB
Bode, BW
Garg, S
Lane, WS
Süssman, A
Hu, P
Santiago, OM
Kolaczynski, J
DIABETES CARE, 2005, 28 (03) : 533 - 538
[2] Transitioning patients with type 1 diabetes from multiple daily injections (MDI) to continuous subcutaneous insulin infusion (CSII)
Kumar, RP
Hirsch, IB
DIABETES, 2004, 53 : A110 - A110
[3] CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) VERSUS MULTIPLE DAILY INJECTION (MDI) THERAPY IN GREEK SUBJECTS WITH TYPE 1 DIABETES
Mouslech, Z.
Somali, M.
Zografou, I.
Sampanis, C.
DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A47 - A47
[4] Glycemic Variability in Adults with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion (CSII) Compared with Multiple Daily Injection (MDI) Treatment
Scott, Emma
Mcgrath, Rachel
Januszewski, Andrzej S.
Calandro, Daniel
O'Neal, David
Fulcher, Greg
Jenkins, Alicia J.
DIABETES, 2017, 66 : A278 - A279
[5] Glucose variability in older adults with type 2 diabetes treated with continuous subcutaneous insulin infusion (CSII) and multiple daily injections of insulin (MDI)
Johnson, Susan L.
McEwen, Laura N.
Newton, Christopher A.
Martin, Catherine L.
Raskin, Philip H.
Herman, William H.
DIABETES, 2007, 56 : A149 - A149
[6] Comparison between multiple daily insulin injection therapy (MDI) and continuous subcutaneous insulin infusion therapy (CSII), results of the five nations study
Hoogma, Roel P. L. M.
Hoekstra, Joost B.
Michels, Bob P.
Levi, Marcel
DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 74 : S144 - S147
[7] Carbohydrate-to-insulin ratio in type 1 diabetic patients treated with continuous subcutaneous insulin infusion therapy (CSII)
Gonzalez, C.
Orellana, I.
Corcoy, R.
Alcantara, V.
Chico, A.
DIABETOLOGIA, 2013, 56 : S444 - S444
[8] A comparison of continuous subcutaneous insulin infusion (CSII) therapy versus multiple daily injection (MDI) therapy with premeal rapid acting insulin and glargine insulin in patients with type 1 diabetes
Mathur, R
Harmel, AP
DIABETES, 2003, 52 : A438 - A438
[9] A CROSSOVER COMPARISON OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) AGAINST MULTIPLE INSULIN INJECTIONS IN INSULIN-DEPENDENT DIABETIC SUBJECTS - IMPROVED CONTROL WITH CSII
HOME, PD
CAPALDO, B
BURRIN, JM
WORTH, R
ALBERTI, KGMM
DIABETES CARE, 1982, 5 (05) : 466 - 471
[10] Effects of Insulin Therapy with Continuous Subcutaneous Insulin Infusion (CSII) in Diabetic Patients: Comparison with Multi-daily Insulin Injections Therapy (MDI)
Derosa, Giuseppe
Maffioli, Pamela
D'Angelo, Angela
Salvadeo, Sibilla A. T.
Ferrari, Ilaria
Fogari, Elena
Mereu, Roberto
Gravina, Alessia
Palumbo, Ilaria
Randazzo, Sabrina
Cicero, Arrigo F. G.
ENDOCRINE JOURNAL, 2009, 56 (04) : 571 - 578

← 1 2 3 4 5 →